48 / 164
48
ESTRO SCHOOL
TARGET GROUP
The course is primarily aimed at trainees in radiation
oncology, supportive care personnel, radiation ther-
apists (RTTs) and at radiation oncologists early in
their career and/or eager to update their knowledge of
general and organ specific morbidity aspects inmodern
radio-(chemo-/targeted-) therapy. For PhD students
in radiation oncology and related disciplines, this
course can broaden their knowledge. As the focus is on
clinical applications, the competences of the teachers’
team comprise radiation oncology, gastroenterology,
psychology and radiobiology.
COURSE AIM
For the lectures, the aims are to:
• Introduce general principles of normal tissue radio-
pathogenesis and radiobiology
• Provide approaches for assessment and documentation
of treatment-related morbidity
• Provide management strategies for “systemic” mor-
bidity (nausea/emesis, fatigue)
• Illustrate important facets of treatment-/morbidity-re-
lated quality of life (including assessment instruments)
and emotional dysfunction
• Provide a comprehensive overview over relevant and
currently accepted approaches for prevention, mitiga-
tion and treatment of adverse events and supportive
care
• Detail specific aspects of morbidity in abdominal
and pelvic radiation oncology (gastrointestinal tract
including. liver and pancreas, urinary tract including
kidney, sexual organs and function).
Complimentary to the lectures, general discussion
sessions and clinical case presentations will serve to
illustrate the relevance of the various aspects of mor-
bidity for daily clinical work, and to answer specific
(morbidity-related) questions.
LEARNINGOUTCOMES
By the end of this course participants should be able to:
• Understand the underlying (radio)biology of treat-
ment-related morbidity
• Identify, classify and document treatment-related
morbidity in cancer survivors
• Identify the impact of treatment-related morbidity
on patients’ quality of life
• Provide strategies for management of systemic
morbidity
• Provide strategies for prevention of treatment-related
morbidity
• Provide supportive care and organ-specific morbidity
management to cancer survivors.
COURSE CONTENT
1. General lectures on:
• The relevance of treatment-related morbidity for
cancer survivors
• General pathogenesis of normal tissue reactions
• Classification and documentation of morbidity
• Reporting: prevalence vs. incidence
• Impact of exposure parameters (4 R’s of radiotherapy)
• Volume effects and tolerance concepts
• General morbidity: fatigue, nausea and emesis
• Quality of life: general aspects, documentation
• Psychological disorders/emotional dysfunction
• Coping with disease and post-disease life
• Management and supportive care guidelines
• Specific aspects of chemo-/immunotherapy.
2. Module-specific lectures on:
• Skin and adnexae
• Spinal cord, peripheral nerves
• Gastrointestinal tract
• Liver and pancreas
• Urinary tract, including kidneys
• Sexual organs and function
• Aspects of paediatric (radio-)oncology.
3. Clinical case discussions:
The participants are invited to collectively discuss
expected (based on treatment protocol and planning)
morbidity and to develop management strategies of
observed adverse events in clinical cases prepared by
the faculty and/or put forward by participants.
Cancer Survivorship
21-23 May 2017
Brussels, Belgium